AN2 Therapeutics ANTX
NASDAQ ANTX
$3.60 +0.04 (+1.12%)
At close: Oct 21, 2026 · 4:00 PM EDT

AN2 Therapeutics (ANTX) Other Non-Current Liabilities (2025 - 2026)

Updated

AN2 Therapeutics (ANTX) reported Other Non-Current Liabilities of $170,000 for Q2 2026, unchanged from the prior quarter.

Analysis

AN2 Therapeutics (ANTX) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 AN2 Therapeutics 160.69 Mn -122.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170,000.00
Mar 31, 2026 170,000.00
Dec 31, 2025 170,000.00
API Access

AN2 Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANTX&period=max&api_key=YOUR_API_KEY